This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Mar;35(5):622-3.

doi: 10.1111/j.1365-2036.2011.04988.x.

Ursodeoxycholic acid in primary sclerosing cholangitis

C K Triantos, N Koukias, V Nikolopoulou, A K Burroughs

PMID: 22300127
DOI: 10.1111/j.1365-2036.2011.04988.x

Comment

Ursodeoxycholic acid in primary sclerosing cholangitis

C K Triantos et al. Aliment Pharmacol Ther. 2012 Mar.

. 2012 Mar;35(5):622-3.

doi: 10.1111/j.1365-2036.2011.04988.x.

Authors

C K Triantos, N Koukias, V Nikolopoulou, A K Burroughs

PMID: 22300127
DOI: 10.1111/j.1365-2036.2011.04988.x

No abstract available

PubMed Disclaimer

Comment on

High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis.
Imam MH, Sinakos E, Gossard AA, Kowdley KV, Luketic VA, Edwyn Harrison M, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, DeCook AC, Enders F, Lindor KD. Imam MH, et al. Aliment Pharmacol Ther. 2011 Nov;34(10):1185-92. doi: 10.1111/j.1365-2036.2011.04863.x. Epub 2011 Sep 29. Aliment Pharmacol Ther. 2011. PMID: 21957881 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.